Author

R. J. Sullivan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Research Focus:differential expression· 4 Approach:statistical model· 4 Research Focus:cell type annotation· 3 Research Focus:cell-cell communication· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Assay:scRNA-seq· 2

Frequent Co-Authors

G. M. Boland· 4 shared D. T. Frederick· 3 shared A. E. Kim· 2 shared A. Mehta· 2 shared E. R. Gerstner· 2 shared K. T. Flaherty· 2 shared M. Martinez-Lage· 2 shared A. Dahal· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

G. M. Boland

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 15, 2023

Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor

S. M. Blum, D. A. Zlotoff, N. P. Smith…·A.-C. Villani

This study identifies immune cell types and biomarkers in irMyocarditis using single-cell RNA sequencing and TCR analysis across heart, blood, and tumor tissues.

DOI 10.1101/2023.09.15.557794

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 25, 2023

Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy

A. E. Kim, K. W. Lou, A. Giobbie-Hurder…·E. R. Gerstner

This study links structural and functional vascular dysfunction in brain metastases to pembrolizumab resistance by analyzing perfusion MRI data from 44 patients.

DOI 10.1101/2023.08.25.554868

humanimaging

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 2, 2022

Plasma proteomic biomarkers identify non-responders and reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockade

A. Mehta, M. Rucevic, E. Sprecher…·G. M. Boland

The paper identifies plasma proteomic biomarkers that predict non-response to PD1 blockade in melanoma patients and links them to tumor microenvironment biology.

DOI 10.1101/2022.02.02.478819

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivAug 25, 2021

Microenvironmental correlates of immune checkpoint inhibitor response in human melanoma brain metastases revealed by T cell receptor and single-cell RNA sequencing

C. A. Alvarez-Breckenridge, S. C. Markson, J. H. Stocking…·Bra

DOI 10.1158/2326-6066.cir-21-0870

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 18, 2019

Plasma-derived exosomal analysis and deconvolution enables prediction and tracking of melanoma checkpoint blockade response

A. Shi, G. G. Kasumova, W. A. Michaud…·G. M. Boland

This paper uses plasma-derived exosomal RNA to predict and track melanoma response to immune checkpoint inhibitors by analyzing tumor and immune signatures.

DOI 10.1101/809699

humanbulk RNA-seq

𝕏 PostBluesky